DEERFIELD, Ill., June 14, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. ("Surgalign") (NASDAQ:SRGA), a global medical technology company focused on elevating the standard of...
Surgalign Holdings (SRGA) shares slide 12.5% on offering ~29M common stock and warrants to purchase up to ~29M common stock at $1.725 per share of common stock and related warrant...
RTI Surgical Holdings, Inc. is a surgical implant company. The Company designs, develops, manufactures and distributes biologic, metal and synthetic implants. The Company's implants are used in orthopedic, spine, sports medicine, plastic surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. It operates in one reportable segment composed of lines of business, including spine, sports and international. The Company manufactures metal and synthetic implants and processes donated human musculoskeletal and other tissue and bovine and porcine animal tissue in producing allograft and xenograft implants using its BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes. The Company's implants are distributed directly to hospitals throughout the United States and in over 50 countries worldwide. It also owns augmented reality and artificial intelligence (ARAI) digital surgery platform.